Home > Healthcare > Medical Devices > Therapeutic Devices > MIS Sacroiliac Joint Fusion Market

MIS Sacroiliac Joint Fusion Market Size

  • Report ID: GMI3848
  • Published Date: Jun 2023
  • Report Format: PDF

MIS Sacroiliac Joint Fusion Market Size

MIS Sacroiliac Joint Fusion Market size was valued at around USD 712 million in 2022 and is estimated to register over 12.1% CAGR between 2023 and 2032. Minimally invasive procedures are gaining popularity in the field of spine surgery due to their advantages such as smaller incisions, reduced trauma, faster recovery, and lower complication rates. MIS sacroiliac joint fusion offers patients a less invasive alternative to traditional open surgery, leading to increased adoption.

 

The MIS sacroiliac joint fusion market has witnessed advancements in surgical techniques and technology, including the development of specialized implants and instrumentation. These advancements aim to improve surgical outcomes, reduce complications, and enhance patient satisfaction. Moreover, there is a growing awareness among healthcare professionals about the potential benefits of MIS sacroiliac joint fusion that may propel the market growth positively.
 

Minimally invasive surgical (MIS) fusion of the sacroiliac joint refers to a surgical procedure performed to stabilize and fuse the sacroiliac (SI) joint using minimally invasive techniques. MIS fusion of the sacroiliac joint is typically performed to treat conditions such as sacroiliac joint dysfunction or degeneration that can cause chronic lower back pain and discomfort. The procedure aims to eliminate or reduce pain by fusing the joint together, thereby limiting its motion and restoring stability.
 

However, the complications associated with sacroiliac Joint fusion procedures may restraint the market revenue. As with any surgical procedure, there is a risk of developing an infection at the surgical site. This can result in pain, swelling, redness, and may require additional treatment with antibiotics or further intervention. During the sacroiliac joint fusion procedure, nearby nerves can be damaged, leading to symptoms such as numbness, weakness, or pain in the legs or lower back. These instances are relatively rare but can require additional medical intervention. Hence, the complications associated with sacroiliac Joint fusion procedures may obstruct the business revenue.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of MIS sacroiliac joint fusion was valued at around USD 712 million in 2022 and will reach over USD 2,071 million by 2032, owing to rising preference for minimally invasive procedures, along with advancements in surgical techniques and technology.

The implants segment reached over USD 458 million in 2022, as these implants are typically designed to facilitate accurate and controlled placement.

U.S. market for MIS sacroiliac joint fusion is set to cross USD 749 million by 2032, owing to a well-established healthcare infrastructure, a large patient population, and a high prevalence of chronic lower back pain that often includes sacroiliac joint dysfunction.

Camber Spine Technologies, LLC, CoreLink Surgical, CornerLoc, Globus Medical, Life Spine, Inc., Medtronic, Orthofix Medical Inc., PainTEQ, and SI-BONE, Inc. among others.

MIS Sacroiliac Joint Fusion Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 438
  • Countries covered: 32
  • Pages: 200
 Download Free Sample